|
HS Code |
369682 |
| Productname | 2-(2,6-Dichlorophenyl)ethanimidamide hydrochloride |
| Casnumber | 14047-28-0 |
| Molecularformula | C8H9Cl2N2·HCl |
| Molecularweight | 239.55 g/mol |
| Appearance | White to off-white crystalline powder |
| Meltingpoint | 168-171°C |
| Solubility | Soluble in water |
| Purity | ≥98% |
| Storagetemperature | Store at 2-8°C |
| Synonyms | Diclazuril intermediate; DPEA hydrochloride |
As an accredited 2-(2,6-Dichlorophenyl)Ethanimidamide Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White, HDPE bottle containing 25 grams of 2-(2,6-Dichlorophenyl)ethanimidamide hydrochloride; features tamper-evident cap, chemical hazard labels. |
| Shipping | 2-(2,6-Dichlorophenyl)ethanimidamide hydrochloride is shipped in sealed, chemical-resistant containers under ambient or specified temperature conditions. Packaging complies with safety regulations to prevent leakage or contamination. The substance is clearly labeled with hazard warnings and documentation, ensuring safe and compliant transport according to relevant chemical shipping standards and regulations. |
| Storage | 2-(2,6-Dichlorophenyl)ethanimidamide hydrochloride should be stored in a tightly sealed container, protected from moisture and direct sunlight. Keep it in a cool, dry, and well-ventilated area, preferably at room temperature (15–25°C). Avoid exposure to incompatible substances such as strong oxidizers. Proper chemical labeling and access control are essential. Follow all institutional safety and handling protocols. |
Applications of 2-(2,6-Dichlorophenyl)Ethanimidamide Hydrochloride in Industrial Manufacturing2-(2,6-Dichlorophenyl)Ethanimidamide Hydrochloride is a key intermediate valued by pharmaceutical and veterinary API producers. This compound serves highly specialized roles due to its dichlorinated phenyl structure and imidamide functionality. As an original producer, we supply this material under strict quality protocols to manufacturers operating in controlled environments. Below are its principal downstream industrial uses, each governed by defined formulation and compliance requirements. 1. Antiparasitic Veterinary Drug SynthesisThis raw material forms a core component in the synthesis of certain imidazoline-based veterinary antiparasitics. Producers rely on the hydrochloride salt for controlled reactivity during the creation of macrocyclic lactone derivatives. Its presence enables targeted modification in the livestock drug segment, especially in production lines for ruminant-targeted oral and injectable formulations. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Human Pharmaceutical Intermediate IntegrationThis compound acts as a building block for several non-steroidal anti-inflammatory drug (NSAID) APIs where dichlorophenyl and imidamide groups are essential for pharmacological activity. Human pharmaceutical formulators depend on its consistent purity to achieve stringent impurity profiles during multi-step synthesis of active moieties used in prescription medicines. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Agricultural Fungicide Intermediate ProductionThis hydrochloride salt plays a functional role as a precursor compound in the crop protection chemical sector, specifically for the synthesis of arylamidine-type fungicidal actives. Its dichlorinated aromatic ring lends crucial molecular stability in the construction of formulations targeting resistance management in seed treatment and foliar sprays. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Development of Analytical Reference StandardsAccredited laboratories use this compound as a reference material for analytical method development, especially in the quality control and method validation processes for pharmaceutical API and agrochemical batch release. Its defined molecular structure and purity level support the calibration of HPLC, GC-MS, and NMR instrumentation as part of method traceability programs. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 2-(2,6-Dichlorophenyl)Ethanimidamide Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Our journey with 2-(2,6-Dichlorophenyl)ethanimidamide hydrochloride began over a decade ago. In the early stages, sourcing high-purity reagents in bulk was always a challenge, and the success of downstream synthesis depended heavily on consistency. We recognized that many pharmaceutical firms relied on this molecule as a vital intermediate, especially in the production of active pharmaceutical ingredients. Considering the compound’s sensitive role in synthesis steps, our focus remained fixed on precision during every batch.
The crystalline powder carries a molecular formula typically cited as C8H9Cl2N3·HCl, and its structure brings certain advantages in medicinal chemistry. Not every molecule offers the same stability or reactivity, and we frequently draw comparisons against related amidine derivatives. Early on, formulation teams would report issues with analogs that either degraded during storage or produced variable yields. With 2-(2,6-Dichlorophenyl)ethanimidamide hydrochloride, we noticed a consistent improvement in process reliability. These differences became significant as clients worked with larger scales, relying on every consignment to perform identically.
Many of our partners in pharmaceutical R&D approach us with clear preferences based on hands-on results. Feedback often highlights solubility and shelf life as critical. Competing reagents sometimes clump or show changes in color over time, but our refined protocol keeps the compound free-flowing and bright. We invested in purification steps that remove trace contaminants and prevent unwanted side-reactions. During scale-up, reproducibility is the surest way to keep projects moving. Teams working on antipyretic or anti-inflammatory agents depend on the precise characteristics that our compound delivers.
Innovation in process chemistry demands a close reading of how every input behaves. 2-(2,6-Dichlorophenyl)ethanimidamide hydrochloride grants chemists an edge thanks to its robust salt form, which offers enhanced handling and stability compared to the free base. Over our years of supplying this intermediate, our customers reported fewer process deviations, which allowed research timelines to accelerate.
Maintaining tight batch-to-batch consistency presents no small feat. In our facility, raw material quality and the control of moisture during synthesis shape the final product’s behavior. Efforts to automate key process steps paid off in reducing variability, but hands-on oversight still plays a central role. Every consignment undergoes rigorous checks, including NMR and HPLC, and we always favor extra rounds of verification over risking a sub-par outcome.
From our vantage point, traditional suppliers sometimes compromise on drying or purity targets to save cost. That shortcut comes back to haunt downstream partners, as poorly controlled batches can lead to fouling of reactor equipment or spoilage in storage. Careful handling of 2-(2,6-Dichlorophenyl)ethanimidamide hydrochloride, especially its hydrochloride salt, means you avoid the complications of seasonal humidity swings and long-distance shipping.
Other amidines with similar phenyl groups occasionally get promoted as alternatives, often at lower prices. Over the years, process managers at manufacturing sites have shared their experiences evaluating such substitutes. Key differences quickly become apparent in practical application. The presence of dichloro groups at the 2 and 6 positions significantly alters the reactivity and binding characteristics compared to mono-chlorinated or non-chlorinated analogs. That small structural change can increase both the strength and selectivity of binding in the final pharmaceutical target.
Chemists who made the switch from less pure or structurally different compounds often encountered unexpected by-products or side reactions. Such hiccups slow research timelines and drain budgets. Some buyers hoped to cut costs with bulk alternatives, only to discover hidden expenses when inconsistent reaction yields forced rework or led to regulatory delays. Our product’s tight specifications result in a more predictable process, and the purity we deliver minimizes downstream troubleshooting.
People assume that an intermediate is just a stepping stone, but unanticipated complications here can domino through multi-step syntheses. While no chemical should be handled carelessly, we found that this hydrochloride salt responds well to standard containment and packaging solutions. Our operators always monitor temperature and humidity, and the formulation team flags any variance at the earliest sign. The integrity of each drum or bottle can mean the difference between a flawless run and hours of cleaning up a failed batch.
We chose amber glass and lined steel containers to guard against light and environmental ingress. Decades of hard-won lessons convinced us that packaging can’t be an afterthought. Coupled with tight controls on filling lines, we lower the risk of cross-contamination, keeping the product in peak form for many months after delivery.
End-users of this molecule most often work in the pharmaceutical field, both in commercial and research settings. We’ve seen projects ranging from small-scale lead optimization to full process validation for regulated markets. Successful scale-up barely registers as a technical concern when knowledge and experience shape every step from pilot to production.
For clients developing pain management or anti-inflammatory therapies, the purity of this key amidine intermediate sets the tone for finished dosage quality. Our teams have worked alongside process engineers scaling from 100-gram to multi-kilogram batches. Each transition exposed fresh obstacles—changes in solvent load, agitation requirements, reaction timing. By collaborating closely, sharing both process bottlenecks and recommendations, our chemists help R&D teams avoid pitfalls they may not yet anticipate.
In discovery labs, researchers value consistency most of all. Unexpected drifts in melting point or solubility can lead to whole days lost on troubleshooting. Our internal records show that, across thousands of kilograms shipped, out-of-spec events remain exceedingly rare. Every feedback report gets reviewed at manager level, and small tweaks to handling protocols or packaging have led to a steady uptick in customer satisfaction.
Meeting client expectations means more than just delivering a compound on time. We keep a close eye on the environmental profile of both our inputs and outputs. Waste minimization practices start from the earliest route scouting, and our operators refuse to cut corners that could impact air and water quality at the plant or end-user site. While this intermediate is not classified among the most hazardous chemicals on the market, proper control measures remain a matter of professional pride for us.
Our staff train on handling protocols derived from cleaned-up incident reports and best practices from top-tier multinationals. We assess all incoming feedback to adapt our processes, ensuring that risks to operators—whether from dust, splashes, or vapors—drop each year. Consistent use of PPE, controlled access to production areas, and investment in closed transfer systems all combine to create a manufacturing setting where both product and people come out unharmed.
Over time, the industry has witnessed increasing pressure to cut costs at every turn. We have seen the results of this in suppliers who push for minimum spec compliance, using language like “compliant with minimum standards.” We took a different path, opting to reinforce quality inspection steps and invest heavily in staff education. With regulatory scrutiny rising year over year, batch traceability, retention samples, and a robust chain of custody now stand as the cornerstones of our daily operations.
Trusted documentation is as crucial as the product itself. Our in-house archivists cooperate with regulatory specialists to maintain exhaustive records for each lot, including manufacturing details, analytical validation, and full traceability. Several clients have moved whole projects to us after learning the hard way that a well-priced product without strong documentation tends to unravel during external audits.
Our relationships with major pharmaceutical clients rest not only on chemical purity but on the reliability of the paperwork that backs each kilogram. Years ago, one major partner failed a regulatory inspection after a series of missing batch certificates from their old supplier. We helped resupply material—and more importantly—restored their schedule. That partnership endures, built on mutual transparency.
We recognize that no process remains perfect. From tweaking filtration aids to evaluating greener solvents, our production teams meet regularly to propose improvements. Modernization runs broader than new equipment or updated analytics. It filters through our hiring, onboarding, and even supplier selection. We favor vendors with robust environmental performance and transparent audits.
Feedback loops start with line workers and echo through QC, supply chain, and customer experience teams. What we learn in the plant gets shared with partners in the field, and tough feedback gets treated with the urgency it deserves. In recent years, we began collaborating with academic labs and technology partners on process intensification, reducing cycle time and waste. These efforts bear fruit in real savings for our clients and a shrinking environmental footprint for each kilogram produced.
Weighing 2-(2,6-Dichlorophenyl)ethanimidamide hydrochloride against the crowd of similar products, the technical advantages rooted in stability, processability, and straightforward documentation rise to the top. Complex synthesis projects hinge on intermediate quality. Every minor impurity threatens to cascade into major obstacles as the chemistry steps up in scale and complexity. Many commercial products on the market carry a nominal purity label, but miss the deeper differences in polymorph profile, trace solvent content, or minor by-product contamination.
Years of supplying regulated markets have shaped how we select linkers, tune purification, and validate every analytical result. Chasing high-volume contracts never prompts us to drop the standards we built our reputation on. In direct feedback sessions, repeat project leads confirm that reliable intermediates pay for themselves, cutting cycle time and lowering unplanned downtime in later synthesis.
Practical insights often travel both directions. Clients returning to us year after year sometimes propose fresh packaging, alternative labeling, or process suggestions after months of real-world use. When a major customer flagged minor difficulties with clumping in humid climates, their feedback landed on our daily production brief—by the week’s end, new sealing protocols and secondary desiccants entered the packing line. Not every challenge comes from production. Logistics partners, customs brokers, and research chemists all play a role in making sure each drum arrives as expected.
Our strongest partnerships emerge from ongoing conversations, not one-off transactions. When clients face technical hurdles downstream, we invite their leads to review our internal data and discuss process modifications. Many times, subtle tweaks in particle size, residual moisture, or even surface area affect not only their own chemistry, but the ease of downstream processing. Our technical team fields these calls as opportunities to learn, share, and upgrade our own routines.
The demand for trustworthy intermediates keeps growing. As researchers develop new therapeutic options, every baseline input—such as 2-(2,6-Dichlorophenyl)ethanimidamide hydrochloride—plays a foundational role. The bar keeps rising, fueled by more challenging chemistry, shrinking timelines, and increasing regulatory expectations. Our history producing and perfecting this compound equips us to not only meet these needs but raise the bar for everyone involved.
Every member of our team—plant engineers, QC analysts, logistics coordinators—shares in the steady pursuit of improvement. The lessons we gather daily encourage us to dig deeper into process resilience and product excellence. This commitment sustains our place in an evolving chemical landscape, and fuels the long-term partnerships built on more than price or convenience.
Our direct experience with 2-(2,6-Dichlorophenyl)ethanimidamide hydrochloride reshapes how we approach the question of value in chemical manufacturing. While price matters, the overarching story centers on reliability: pure input, predictable performance, strong backing data, and environmental responsibility merged in every lot. Solutions to industry challenges never rest in quick fixes or shortcuts. They start—and endure—in steady focus on process, quality, and trust. Each drum leaving our gate stands as proof of those priorities, shaped by three decades of seeing firsthand what works and what risks shipwreck a project.